Smiths Falls, ON
Canopy Growth is a world-leading diversified cannabis, hemp and cannabis device company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms, as well as medical devices through Canopy Growth’s subsidiary, Storz & Bickel GMbH & Co. KG.
Toronto, ON
Canopy Rivers (TSXV:RIV) is a unique investment and operating platform structured to pursue opportunities in the emerging global cannabis sector.
Miami, FL
Cansortium is the largest US Based, international, vertically integrated medical cannabis company in the world. Our goal is to lead the industry in understanding product formulation efficacy to create greater yields and potency with higher efficiency.
Stamford, CT
Cara Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing a novel class of peripherally acting kappa opioid agonist therapeutics with a primary focus for the treatment of pruritus
Charlotte, NC
cbdMD combines premium quality and innovation to offer the purest CBD available on the market. Testing their broad-spectrum CBD extractions through independent, third-party laboratories to guarantee the highest of standards. cbdMD is committed to providing the best in CBD
Arvada, CO
Dealcoholized cannabis-infused brands including Colorado's first THC-infused beer, Grainwave Belgian-Style White Ale. Extraordinary non alcoholic craft beers created by legendary brewmaster Keith Villa.
Burlington, VT
Boulder, CO
Charlotte's Web Holdings, Inc. produces and distributes hemp-based cannabidiol wellness products in the United States. The company offers products in the categories of tinctures, capsules, gummies, topicals, and pet products.
clēēn:hemp products are the first step in this carbon-eating, positive feedback loop as they will increase the demand for industrial hemp, thus proliferating hemp biomass and reducing the planet’s oversupply of retained carbon dioxide.
Clever Leaves is a Global Company with offices in Canada, Colombia, Germany, Portugal and United States. We have raised $100 million of capital and are focused on new development projects, leveraging best practices from other industries to build sophisticated, EuGMP cannabis assets.